A REACTION OF HEART RATE VARIABILITY SPECTRAL PARAMETERS IN THE PHARMACOLOGICAL TEST WITH MEBICAR IN HEALTHY VOLUNTEERS
Abstract
On 13 conditionally healthy volunteers aged from 18 to 46 years (mean age – 22±7,6 years) the variability of the total power (TP, ms2) of the spectrum, very low frequency (VLF, ms2), low frequency (LF, ms2) and high frequency (HF, ms2) domains of heart rate variability (HRV) in 5 minute intervals of ECG in I standard lead before and 30 minutes after oral admission of 500 mg of mebicar were evaluated. The data were processed by methods of nonparametric statistics. No significant changes in TP, VLF, LF, HF HRV after 30 minutes (maximum time declared by pharmacodynamics action) after administration of 500 mg of mebicar were noted by us. Accordingly, the effectiveness of mebicar as an adaptogen without evidence-based research cannot be postulated.Downloads
References
Panossian A. Stimulating Effect of Adaptogens: An Overview with Particular Reference to their Efficacy following Single Dose Administration. / A. Panossian, H. Wagner. // Phytotherapy Research, Wiley Online Library. – 2005. – 19. – P. 819–838.
Mokina T. V. Use of Adaptol in the Treatment of Chronic Fatigue Syndrome in Patients with Chronic Cerebral Ischemia. / T. V. Mokina, E. A. Antipenko, A. V. Gustov. // Neuroscience and Behavioral Physiology. – 2010. – 40 (7). – P.757–759.
Khaziakhmetova V. N. Experimental comparative study of the analgesic activity of the diurnal anxiolytic mebicar, amitriptyline, and diazepam. / V. N. Khaziakhmetova, K. V. Luchai, L. E. Ziganshina. // Eksperimental'naja i Klinicheskaja Farmakologija. – 2015. – 78 (3). – P. 9–12.
Benoît Tavernier, Mathieu Jeanne. Monitoring Technologies in Acute Care Environments; 2013. – P. 109–115.
Rhoades R.A. Medical Physiology: Principles for Clinical Medicine. 4th ed. / R.A. Rhoades, D.R. Bell. – Baltimore, MD: Lippincott Williams & Wilkins, a Wolters Kluwer business; 2013. – P. 311–325.
Grippo A.J. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models / A. J. Grippo, A. K. Johnson // Stress. – 2009. – № 12 (1). – Р. 1–21.
Mebikar [Yelektronniy resurs]. – Rezhim dostupu do resursu: http://www.piluli.kharkov.ua/drugs/drug/mebikar/.
Yabluchanskiy N.I., Martynenko A.V. Variabel'nost' serdechnogo ritma v pomoshch' prakticheskomu vrachu. Dlya nastoyashchikh vrachey. Khar'kov, 2010, 131 s.
Kivimäki M. Work Stress as a Risk Factor for Cardiovascular Disease / M. Kivimäki, I. Kawachi // Curr Cardiol Rep. – 2015. – Vol. 17 (9). – p. 630.
Cavigelli S. A. Sex, social status and physiological stress in primates: the importance of social and glucocorticoid dynamics / S. A. Cavigelli, M. J. Caruso // Philos Trans R Soc Lond B Biol Sci. – 2015. – Vol. 370(1669). – p. 20140103.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
